
The world needs to quickly roll out safe and effective #COVID19 vaccines to accompany other pandemic control measures. #VaccinesWork #VaccineEquity Support @WHO
Global
Joined February 2009
- Tweets1.5K
- Following443
- Followers1.5K
- Likes544
Great news here at #Hepatology, Medicine and Policy (#HMAP) - We are formally a @PubMedHealth indexed journal (!) & always #openaccess. See our @BioMedCentral home for cutting-edge articles on hepatology, #hepatitis, submission guidelines & more hmap.biomedcentral.com/ @JVLazarus
New review in #HMAP: Strategies for achieving #HCV #microelimination in the Netherlands. Emblematic national ex of connecting highest risk pops to care for @WHO goal: eliminate HCV as #publichealth threat by 2030 #NOhep @BioMedCentral @UniUtrecht @rivm
ow.ly/1Elu30m9xE2
New in #HMAP #openaccess: THE #systematicreview of #hepatitis B & C seroprevalence in Nepal 1973-2017. Mobilization for viral hep #elimination requires thorough national data. @UNAIDSNepal @WHOSEARO @gavi @Hep_Alliance @nepalitimes #NOhep #SoutheastAsia
hmap.biomedcentral.com/artic…
Just out in #HMAP: Drug consumption rooms as setting to address #hepatitis C – findings from int'l survey
#openaccess research on avail of services in #DCRs https://teapawt.org/t.co/LLa38jfH7K @INHepSU @DrugPolicy_DPMP @HRInews @NVHR1 @KirbyInstitute @BioMedCentral #harmreduction #NOhep
New in #Hepatology, Medicine and Policy: Qual research on #patientexperience of achieving #HCV cure using #DAAs in Australia. Finding cure = finding normal - & #PWID must be aware of option for re-treatment @HepAus @LTU_Sex_Health @INHepSU #NOhep #HMAP #openaccess @BioMedCentral
New in #HMAP #openaccess: Researchers quantify #HBV in California, US state w/ highest burden of chronic HBV & related #livercancer in the country.
@BioMedCentral @asianliverctr @StanfordMed @Stanford_GI @JVLazarus #NOhep hmap.biomedcentral.com/artic…
New in #HMAP: France removed #hepatitis C #treatment reimbursement restrictions on 25 May 2016. Authors of this report lay out 7 reccs for strengthening impact of this move. Fascinating read/model for across Europe @BioMedCentral @Cermes3 @JVLazarus #NOhep hmap.biomedcentral.com/artic…
Considering central role of people, patient engagement, & communication as #HealthSystem building blocks to effectively support clinical #HCV elimination efforts @JVLazarus. Good morning #EASLmono, let's do some paradigm shifting. @EASLedu @Hep_Alliance @HepatitisEurope #NOhep
Philippa Easterbrook echoing @jasongrebely etc but on lessons learned from #HIV, critical need to change from filtering every stage of care through tertiary care clinic, #HCV care should be disseminated in community and delegated to varied providers. #EASLmono
Join those of us at #EASLmono in Berlin. Such a wonderfully full schedule that the discussion is ongoing in person during Q&As and breaks, but on Twitter during the sessions themselves. @EASLedu @aelsharkawy75 @JVLazarus @jasongrebely @AghemoAlessio @StineNielsenEPI and many more
Great talk by Andrea Cox on the possibility and ramifications of potential #HCV #vaccines. We talk about #treatment regularly but she remarks that vaccines have historically been the only way we've fully achieved disease control especially as risk factors vary globally. #EASLmono
Appropriate to start off #EASLmono conference w/ presentation by Andi Hüttenmoser, former patient talking about 35-year experience with #HCV. After all - 275 participants are here bright and early in a blue-lit conference room in Berlin b/c of the patients. #elimination @EASLedu
1
5
Our #openaccess #Hepatology, Medicine & Policy journal covers more than 'just' viral #hepatitis. See newest #HMAP article on the design of the #PROSPER study: hepatic encephalopathy patients’ experience on rifaximin-α. @EASLedu @BioMedCentral #LiverDisease ow.ly/ibYP30hZ0CU
Clinicians must recognize need to test for #hepatitis B in HIV-infected patients, even in low-resource settings. See "Uptake of hepatitis B-HIV co-infection screening & management in a resource limited setting" in #HMAP now ow.ly/H2i230hYLkk @WHO @BioMedCentral #openaccess
New in #HMAP: What do you think are the most important unmet #treatment needs of viral #hepatitis B and C patients? Keep the debate going ow.ly/bho830hYKYJ
















